|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/35 | |
| A61K 9/48 | |||
| A61J 3/00 | |||
| A61J 3/07 | |||
| C07K 16/16 |
| (11) | Patento numeris | 2968529 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14776121.7 |
| Europos patento paraiškos padavimo data | 2014-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/024401 |
| Data | 2014-03-12 |
| (87) | Numeris | WO 2014/159607 |
| Data | 2014-10-02 |
| (30) | Numeris | Data | Šalis |
| 201361784964 P | 2013-03-14 | US |
| (72) |
WALSER, Bryan, US
RAFF, Howard, V., US
|
| (73) |
Aimmune Therapeutics, Inc.,
8000 Marina Boulevard Suite 300, Brisbane, CA 94005-1884,
US
|
| (54) | MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION |
| MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION |